Cytokeratin immunolocalization and lectin binding studies in oesophageal squamous dysplasia

Histopathology

Volumn 29, Issue 1, 1996, Pages 3-10

  Itakura, Y ^a   Sasano, H ^a   Abe, K ^a   Furukawa, Y ^a   Mori, S ^a   Nagura, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Lectins; Oesophagus; Squamous dysplasia

Indexed keywords

CYTOKERATIN; LECTIN;

ANTIGEN EXPRESSION; ARTICLE; EPITHELIUM DYSPLASIA; ERYTHRINA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LECTIN BINDING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030015734     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-480.x     Document Type: Article

References (29)

1. Jacob P, Kahrilas PJ, Desai T et al. Natural history and significance of esophageal squamous cell dysplasia. Cancer 1990; 65; 2731-2739.
2. Jaskiewicz K, Venter FS, Marasas WF. Cytopathology of the esophagus in Transkei. JNCI 1987; 79; 961-967.
3. Munoz N, Crespi M, Grassi A et al. Precursor lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet 1982; 1 876-879.
4. Ohta H, Nakazawa S, Segawa K et al. Distribution of epithelial dysplasia in the cancerous esophagus. Scand. J. Gastroenterol. 1986; 21; 392-398.
5. Qiu S, Yang G. Precursor lesions of esophageal cancer in high-risk populations in Henan province, China. Cancer 1988: 62; 551-557.
6. Yang CS. Research on esophageal cancer in China. A review. Cancer Res. 1980: 40; 2633-2644.
7. Mukada T, Sasano N, Sato E. Evaluation of esophageal dysplasia by cytofluorometric analysis. Cancer 1978; 41; 1399-1404.
8. Rubio CA, Auer GU, Kato Y et al. DNA profiles in dysplasia and carcinoma of the human esophagus. Anal. Quant. Cytol. Histol. 1988; 10; 207-210.
9. Sasaki T. The Study of DNA content in esophageal cancer. Tohoku J. Med. 1980; 93; 13-23.
10. Wang LD, Hong JY, Qiu SL et al. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carinogenesis. Cancer Res. 1993; 53; 1783-1787.
11. Jaskiewicz K, De Groot KM. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Anticancer Res. 1994; 14; 137-140.
12. Itakura Y, Sasano H, Mori S et al. DNA ploidy in human esophageal squamous dysplasias and squamous cell carcinomas as determined by image analysis. Modern Pathology 1994; 7; 867-873.
13. Wang LD, Lipkin M, Qui SL et al. Labeling index and labeling distribution of cells in esophageal epithelium of individuals at increased risk for esophageal cancer in Huixian, China. Cancer Res. 1990; 50; 2651-2653.
14. Sasano H, Goukon Y, Nishihira T et al. In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. Am. J. Pathol. 1992; 141; 545-550.
15. Hurlimann J, Gardiol D. Immunohistochemistry of dysplasias and carcinomas of the esophageal epithelium. Path. Res. Pract. 1989; 184; 567-576.
16. Sato E, Maruta K, Yonezawa S et al. Blood group H(O) antigen in normal, dysplastic and carcinomatous esophageal epithelium. Gann. 1984; 75; 223-229.
17. Yang K, Liu Y, Lipkin M et al. Precancerous lesions of the human esophagus: multiparametric study of esophageal biopsies from a high-risk population in Linxian, China. J. Cell Biochem. Suppl. 1992; 16G; 187-194.
18. Japanese Society for Esophageal Diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Tokyo: Kinbara Co. Ltd., 1992.
19. McCormick D, Chong H, Hobbs C et al. Detection of the Ki-67 antigen in fixed and wax-embedeed sections with the monoclonal antibody MIB1. Histopathology 1993; 22; 355.
20. Sasano H, Imatani A, Shizawa S et al. Cell proliferation and apoptosis in normal and pathologic human adrenal. Modern Pathology 1995; 8; 11-17.
21. Sasano H, Saito Y, Nagura H et al. Lectin histochemistry in mucinous and serous ovarian neoplasms. Int. J. Gynecol. Pathol. 1991; 10; 252-259.
22. Sasano H, Nose M, Sasano N. Lectin histochemistry in adrenocortical hyperplasia and neoplasms with emphasis on carcinoma. Arch. Pathol. Lab. Med. 1989; 113; 68-72.
23. Schaafsma HE, Van Der Velden LA. Manni JJ et al. Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J. Pathol. 1993; 170; 77-86.
24. Yang K, Lipkin M, AE1 cytokeratin reaction patterns in different differentiation states of squamous cell carcinoma of the esophagus. Am. J. Clin. Pathol. 1990; 94; 261-269.
25. Moll R, Krepler R, Franke WW. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983; 25; 256-269.
26. Banks-Schlegel SP, Harris CC. Aberrant expression of keratin proteins and cross-linked envelopes in human esophageal carcinomas. Cancer Res. 1984; 44; 1153-1157.
27. Grace MP, Kim KH, True LD et al. Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus. Cancer Res. 1985; 4; 841-846.
28. Viaene AI, Baert JH. Expression of cytokeratin-mRNAs in squamous-cell carcinoma and balloon-cell formation of human oesophageal epithelium. Histochemical J. 1995; 27; 69-78.
29. Takahashi H, Shikata N, Senzaki H et al. Immunohistochemical staining patterns of keratins in normal oesophageal epithelium and carcinoma of the oesophagus. Histopathology 1995; 26; 45-50.